ALKS
Price:
$44.99
Market Cap:
$7.50B
Alkermes plc is an Irish-headquartered biopharmaceutical firm, established in 1987, focused on the discovery, development, and commercialization of innovative pharmaceutical treatments. These efforts are directed at fulfilling critical unmet medical needs for patients across a range of therapeutic areas, both domestically and internationally. Its current portfolio of marketed products features ARISTADA for schizophrenia; VIVITROL, targeting alcohol dependence and preventing opioid dependence; and several medications for schizophrenia and bipolar I disorder, including RISPERDAL CONSTA, INVEGA SUSTENNA, XEPLION, INVEGA TRINZA, and TREVICTA. Furthermore, VUMERITY is available for managing relap...[Read more]
Industry
Biotechnology
IPO Date
1991-07-16
Stock Exchange
NASDAQ
Ticker
ALKS
According to Alkermes plc’s latest financial reports and current stock price. The company's current PE Ratio is 49.99. This represents a change of 573.00% compared to the average of 7.43 of the last 4 quarters.
The mean historical PE Ratio of Alkermes plc over the last ten years is -23.05. The current 49.99 PE Ratio has changed -21783.87% with respect to the historical average. Over the past ten years (40 quarters), ALKS's PE Ratio was at its highest in in the December 2021 quarter at 1.08K. The PE Ratio was at its lowest in in the September 2020 quarter at -5178.13.
Average
-23.05
Median
-27.72
Minimum
-77.53
Maximum
19.03
Discovering the peaks and valleys of Alkermes plc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 172.05%
Maximum Annual PE Ratio = 19.03
Minimum Annual Increase = -148.12%
Minimum Annual PE Ratio = -77.53
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 19.03 | 46.92% |
| 2024 | 12.95 | -0.06% |
| 2023 | 12.96 | -148.12% |
| 2022 | -26.94 | -65.26% |
| 2021 | -77.53 | 172.05% |
| 2020 | -28.50 | 74.63% |
| 2019 | -16.32 | -50.23% |
| 2018 | -32.79 | -38.29% |
| 2017 | -53.14 | 31.93% |
| 2016 | -40.28 | -22.88% |
The current PE Ratio of Alkermes plc (ALKS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
14.98
5-year avg
-11.90
10-year avg
-23.05
Alkermes plc’s PE Ratio is greater than PTC Therapeutics, Inc. (-33.84), greater than Arcellx, Inc. (-28.27), greater than Protagonist Therapeutics, Inc. (-62.63), greater than ACADIA Pharmaceuticals Inc. (9.70), greater than TG Therapeutics, Inc. (16.74), greater than Arrowhead Pharmaceuticals, Inc. (-38.23), greater than Vaxcyte, Inc. (-7.47), greater than CRISPR Therapeutics AG (-8.70), greater than Akero Therapeutics, Inc. (-14.61), greater than Kymera Therapeutics, Inc. (-25.26),
| Company | PE Ratio | Market cap |
|---|---|---|
| -33.84 | $6.55B | |
| -28.27 | $6.73B | |
| -62.63 | $7.26B | |
| 9.70 | $3.70B | |
| 16.74 | $8.15B | |
| -38.23 | $11.52B | |
| -7.47 | $7.43B | |
| -8.70 | $5.22B | |
| -14.61 | $4.50B | |
| -25.26 | $7.44B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alkermes plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Alkermes plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Alkermes plc's PE Ratio?
How is the PE Ratio calculated for Alkermes plc (ALKS)?
What is the highest PE Ratio for Alkermes plc (ALKS)?
What is the 3-year average PE Ratio for Alkermes plc (ALKS)?
What is the 5-year average PE Ratio for Alkermes plc (ALKS)?
How does the current PE Ratio for Alkermes plc (ALKS) compare to its historical average?